Live News EQUITY FLASH L impact Nov 04, 2026, 12:31 PM UTC NewAmsterdam Pharma Reports 3Q R&D Expenses of $39.4M Valid market news retained in the public archive without immediate LiveCast distribution. NAMS SquawkNews Desk